US Stock MarketDetailed Quotes

AMGN Amgen

Watchlist
  • 327.360
  • +2.500+0.77%
Close Mar 10 16:00 ET
  • 328.020
  • +0.660+0.20%
Pre 07:08 ET
175.86BMarket Cap43.30P/E (TTM)

About Amgen Company

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Company Profile

SymbolAMGN
Company NameAmgen
Listing DateJun 1, 1983
Issue Price18.00
Founded1980
CEOMr. Robert A. Bradway
MarketNASDAQ
Employees28000
Fiscal Year Ends12-31
AddressOne Amgen Center Drive
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320-1799
Phone1-805-447-1000
Websitehttp://www.amgen.com

Company Executives

  • Name
  • Position
  • Salary
  • Robert A. Bradway
  • Chairman of the Board, President and Chief Executive Officer
  • 22.64M
  • Matthew C. Busch
  • Vice President, Finance and Chief Accounting Officer
  • --
  • Nancy A. Grygiel
  • Senior Vice President and Chief Compliance Officer
  • --
  • Dr. David M. Reese, M.D.
  • Executive Vice President and Chief Technology Officer
  • 7.90M
  • Peter H. Griffith
  • Executive Vice President and Chief Financial Officer
  • 6.02M
  • Rachna Khosla
  • Senior Vice President, Business Development
  • --
  • Murdo Gordon
  • Executive Vice President, Global Commercial Operations
  • 8.24M
  • Jonathan P. Graham
  • Executive Vice President, General Counsel and Secretary
  • --
  • Derek Miller
  • Senior Vice President, Human Resources
  • --
  • Esteban Santos
  • Executive Vice President, Operations
  • 7.21M
  • Dr. James E. Bradner, M.D.
  • Executive Vice President, Research and Development
  • --
  • Ellen J. Kullman
  • Independent Director
  • 360.29K
  • Michael V. Drake
  • Independent Director
  • 339.92K
  • Dr. Wanda M. Austin
  • Independent Director
  • 359.92K
  • Professor Dr. Tyler E. Jacks, PhD
  • Independent Director
  • 339.92K
  • Dr. S. Omar Ishrak
  • Independent Director
  • 366.47K
  • Dr. Brian J. Druker, M.D.
  • Independent Director
  • 359.92K
  • Mary E. Klotman
  • Independent Director
  • --
  • Robert A. Eckert
  • Lead Independent Director
  • 419.92K
  • Greg C. Garland
  • Independent Director
  • 379.92K
  • Amy E. Miles
  • Independent Director
  • 359.92K
  • Charles M. Holley, Jr
  • Independent Director
  • 369.92K

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Lantheus
LNTH
110.010
Collegium Pharmaceutical
COLL
29.660
Constellation Brands
STZ
189.470
4
Halozyme Therapeutics
HALO
61.440
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
12.200
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!